STIM | Neuronetics, Inc.

Healthcare | Diagnostics & Research | USA | NASD

Index	-	P/E	-	EPS (ttm)	-1.35	Insider Own	6.20%	Shs Outstand	28.03M	Perf Week	-12.55%
Market Cap	68.99M	Forward P/E	-	EPS next Y	-1.06	Insider Trans	-21.84%	Shs Float	26.16M	Perf Month	-15.66%
Income	-36.80M	PEG	-	EPS next Q	-0.35	Inst Own	69.10%	Short Float / Ratio	1.30% / 1.61	Perf Quarter	-25.24%
Sales	66.60M	P/S	1.04	EPS this Y	-12.80%	Inst Trans	-2.04%	Short Interest	0.34M	Perf Half Y	-62.02%
Book/sh	1.72	P/B	1.38	EPS next Y	20.90%	ROA	-31.90%	Target Price	8.67	Perf Year	-31.30%
Cash/sh	1.90	P/C	1.25	EPS next 5Y	-	ROE	-62.20%	52W Range	2.01 - 6.95	Perf YTD	-65.50%
Dividend	-	P/FCF	-	EPS past 5Y	-6.90%	ROI	-37.80%	52W High	-65.91%	Beta	1.91
Dividend %	-	Quick Ratio	4.80	Sales past 5Y	10.00%	Gross Margin	75.70%	52W Low	17.91%	ATR	0.23
Employees	200	Current Ratio	5.40	Sales Q/Q	9.20%	Oper. Margin	-52.50%	RSI (14)	37.86	Volatility	7.98% 9.12%
Optionable	Yes	Debt/Eq	0.76	EPS Q/Q	7.90%	Profit Margin	-55.30%	Rel Volume	0.52	Prev Close	2.42
Shortable	Yes	LT Debt/Eq	0.76	Earnings	May 09 BMO	Payout	-	Avg Volume	211.12K	Price	2.37
Recom	2.00	SMA20	-12.18%	SMA50	-5.84%	SMA200	-42.01%	Volume	109,983	Change	-2.07%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Jun-09-23 09:50AM	Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger (Zacks)
08:53AM	Charles River (CRL) to Aid INADcure in Plasmid DNA Manufacture (Zacks)
Jun-08-23 12:18PM	Neuronetics, Inc. (NASDAQ:STIM) Could Be Riskier Than It Looks (Simply Wall St.)
09:31AM	Bruker (BRKR) Launches timsTOF Ultra Mass Spec and VistaScan (Zacks)
Jun-06-23 11:19AM	Quest Diagnostics' (DGX) Contract Wins Aid Amid Volume Woes (Zacks)
08:04AM	Loading…
08:04AM	Bruker's (BRKR) Latest Workflows to Aid Applied Markets (Zacks)
Jun-02-23 10:26AM	Walgreens Boots (WBA) Gains From New Alliances Amid Macro Woes (Zacks)
08:33AM	Neogen (NEOG) Introduces 2 Assays for Histamine Detection (Zacks)
Jun-01-23 08:39AM	LabCorp (LH) Expands Precision Oncology With Biopsy Test (Zacks)
May-31-23 09:16AM	Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23 (Zacks)
May-30-23 01:50PM	Neuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression (News Direct) -5.14%
May-29-23 02:06AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Revised) (Zacks)
May-26-23 08:59AM	Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan (GlobeNewswire) +6.18%
May-25-23 12:25PM	Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio (Zacks)
May-24-23 04:30PM	Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
09:34AM	Loading…
09:34AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Zacks)
May-23-23 10:10AM	Exact Sciences (EXAS) Gains From New Buyouts Amid High Costs (Zacks)
08:46AM	New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction (GlobeNewswire)
May-22-23 08:01AM	Thermo Fisher (TMO) Gets FDA Clearance for Its Immunoassays (Zacks)
May-18-23 10:16AM	Illumina (ILMN) Progresses in Pathogen Genomic Technologies (Zacks) -6.88%
May-17-23 11:09AM	Hologic (HOLX) Announces Collaboration With NFL CB Kelee Ringo (Zacks)
May-15-23 08:56AM	Neuronetics Wins 2023 Bell Seal for Workplace Mental Health (GlobeNewswire)
07:58AM	Integra (IART) Builds Advanced R&D Facility in New Jersey (Zacks)
May-09-23 05:00PM	Neuronetics to Present at the JMP Securities Life Sciences Conference (GlobeNewswire) +27.27%
08:55AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Neuronetics Reports Record First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-08-23 08:47AM	Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR (GlobeNewswire)
May-05-23 08:30AM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-03-23 08:58AM	Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting (GlobeNewswire)
May-02-23 09:01AM	NeuroStar® Expands Tap Into Possibility Campaign in Honor of Mental Health Awareness Month (GlobeNewswire)
08:46AM	Loading…
May-01-23 08:46AM	Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer (GlobeNewswire)
Apr-28-23 04:11PM	Neuronetics Announces Expanded TMS Access through United HealthCare (GlobeNewswire)
Apr-25-23 08:30AM	Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-18-23 02:14PM	Further weakness as Neuronetics (NASDAQ:STIM) drops 11% this week, taking one-year losses to 25% (Simply Wall St.)
Apr-13-23 08:58AM	Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy (GlobeNewswire)
Apr-06-23 04:16PM	NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities (GlobeNewswire) -9.38%
Apr-04-23 08:30AM	Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note (GlobeNewswire)
Mar-16-23 08:56AM	NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA (GlobeNewswire)
Mar-08-23 10:02PM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.93%
12:44AM	Q4 2022 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 08:45AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -19.19%
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-02-23 04:02PM	Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives (GlobeNewswire) -5.26%
Feb-27-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-23-23 08:56AM	Neuronetics Expands NeuroStar® Advanced Therapys Proprietary TrakStar® Platform (GlobeNewswire) -10.02%
Feb-22-23 04:35PM	Neuronetics to Report Fourth Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-21-23 08:53AM	Neuronetics Sponsors the 5th International Brain Stimulation Conference (GlobeNewswire)
Feb-16-23 04:12PM	Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer (GlobeNewswire)
Feb-10-23 04:15PM	Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners (GlobeNewswire)
Jan-19-23 10:50AM	Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS (Benzinga)
08:30AM	Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership (GlobeNewswire)
Jan-18-23 04:29PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.35%
Jan-17-23 08:32AM	Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health (GlobeNewswire)
Jan-10-23 12:27PM	Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay (Benzinga)
08:00AM	Neuronetics Settles Litigation Against BrainsWay (GlobeNewswire)
Jan-09-23 08:30AM	Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire)
Dec-29-22 04:29PM	Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors (GlobeNewswire)
Dec-27-22 09:04AM	5 Winning Medical Product Stocks That Still Have Room to Run (Zacks)
Dec-23-22 09:40AM	Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-22-22 06:42AM	Owning 50% shares,institutional owners seem interested in Neuronetics, Inc. (NASDAQ:STIM), (Simply Wall St.)
Dec-07-22 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-06-22 12:00PM	Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know (Zacks)
Dec-05-22 08:32AM	Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category (GlobeNewswire)
Nov-21-22 04:30PM	Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) -6.23%
Nov-14-22 08:33AM	Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations (GlobeNewswire)
Nov-10-22 09:48AM	Neuronetics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.) +7.50%
Nov-09-22 08:04PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.53%
09:46AM	The past year for Neuronetics (NASDAQ:STIM) investors has not been profitable (Simply Wall St.)
Nov-08-22 08:45AM	Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Neuronetics Reports Third Quarter 2022 Financial and Operating Results (GlobeNewswire)
Oct-31-22 08:31AM	Neuronetics Announced as Winner by 2022 Merit Awards for Technology (GlobeNewswire)
Oct-25-22 10:31AM	Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health (GlobeNewswire)
08:30AM	Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Sep-26-22 08:31AM	Neuronetics Launches Innovations To NeuroStar® Advanced Therapys Proprietary TrakStar® Platform (GlobeNewswire)
Sep-13-22 08:33AM	Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting Ceremony (GlobeNewswire)
Aug-30-22 12:43PM	Is Neuronetics (NASDAQ:STIM) Using Too Much Debt? (Simply Wall St.)
Aug-29-22 08:30AM	Neuronetics Announces 510(k) Clearance of D-Tect MT Accessory for NeuroStar® Advanced Therapy for Mental Health (GlobeNewswire) -6.51%
Aug-08-22 09:55AM	Neuronetics (STIM) Just Flashed Golden Cross Signal: Do You Buy? (Zacks) -8.37%
Aug-05-22 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.67%
Aug-02-22 10:30PM	Neuronetics, Inc. (STIM) Q2 2022 Earnings Call Transcript (Motley Fool)
09:15AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Neuronetics Reports Second Quarter 2022 Financial and Operating Results (GlobeNewswire)
Jul-29-22 11:00AM	Lab Notes: Marken opens Malvern clinical trial logistics depot, Strata launches new acne treatment and more (American City Business Journals)
Jul-28-22 04:30PM	Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
Jul-25-22 08:31AM	Neuronetics and Alleviant Health Centers Announce Exclusive Partnership (GlobeNewswire)
Jul-19-22 08:57AM	Neuronetics gets another FDA clearance for transcranial magnetic stimulation system; shares jump 22% (MarketWatch)
08:30AM	Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
07:52AM	Read Why Neuronetics Shares Are Trading Higher Today (Benzinga)
07:00AM	NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression (GlobeNewswire)
Jul-15-22 06:08AM	What Kind Of Investors Own Most Of Neuronetics, Inc. (NASDAQ:STIM)? (Simply Wall St.)
Jul-13-22 08:31AM	Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022 (GlobeNewswire) +5.71%
Jul-11-22 04:46PM	Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health (GlobeNewswire)
Jun-27-22 02:55PM	Activist investor takes 13% stake in Malvern-based Neuronetics, seeks board seat (American City Business Journals)
07:43AM	ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Jun-24-22 02:48PM	Neuronetics, New Relic Stocks See Action From Activist Investors (Barrons.com) -7.14%
May-27-22 07:20AM	Neuronetics (NASDAQ:STIM) investors are sitting on a loss of 82% if they invested a year ago (Simply Wall St.) +11.67%
May-25-22 04:30PM	Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference (GlobeNewswire)
May-17-22 08:31AM	New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy (GlobeNewswire)
May-12-22 05:00PM	Neuronetics, Inc. (STIM) Q1 2022 Earnings Call Transcript (Motley Fool) +8.13%
02:06PM	Neuronetics gets FDA approval for wider use of its NeuroStar treatment system (American City Business Journals)

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAKEWELL JOHN K	Director	May 24	Sale	2.70	14,400	38,880	77,988	May 26 04:10 PM
CANNELL CAPITAL LLC	10% Owner	Mar 17	Buy	2.89	7,644	22,091	3,127,819	Mar 20 07:40 PM
CANNELL CAPITAL LLC	10% Owner	Mar 16	Buy	2.90	52,072	151,009	3,120,175	Mar 20 07:40 PM
CANNELL CAPITAL LLC	10% Owner	Mar 13	Buy	2.97	136,520	405,464	3,068,103	Mar 15 05:25 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Mar 07	Sale	4.59	12,692	58,256	387,847	Mar 09 04:09 PM
Furlong Stephen	EVP, CFO and Treasurer	Mar 07	Sale	4.59	11,079	50,853	431,055	Mar 09 04:08 PM
CANNELL CAPITAL LLC	10% Owner	Mar 07	Sale	4.71	7,746	36,484	2,931,583	Mar 09 05:43 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 16	Sale	5.91	11,044	65,270	400,539	Feb 17 04:45 PM
Furlong Stephen	CFO	Feb 15	Sale	5.90	13,148	77,573	442,134	Feb 16 05:17 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 15	Sale	5.90	11,974	70,647	411,583	Feb 17 04:45 PM
Sullivan Keith J	President and CEO	Feb 14	Sale	5.58	13,647	76,150	1,197,198	Feb 15 04:43 PM
Furlong Stephen	CFO	Feb 14	Sale	5.58	12,403	69,209	455,282	Feb 16 05:17 PM
Sullivan Keith J	President and CEO	Feb 13	Sale	5.49	25,154	138,095	1,210,845	Feb 15 04:43 PM
Furlong Stephen	CFO	Feb 07	Sale	5.99	5,584	33,448	367,685	Feb 09 05:43 PM
MACAN WILLIAM ANDREW	SVP and General Counsel	Feb 07	Sale	5.99	5,162	30,920	333,557	Feb 09 05:48 PM
MACAN WILLIAM ANDREW	SVP and General Counsel	Jan 23	Sale	5.96	16,046	95,634	338,719	Jan 24 04:09 PM
Furlong Stephen	CFO	Jan 17	Sale	6.13	16,050	98,386	373,269	Jan 18 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Jan 17	Sale	6.31	2,912	18,375	2,939,329	Jan 19 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 13	Sale	6.30	4,896	30,845	2,942,241	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 12	Sale	6.30	12,397	78,101	2,947,137	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 11	Sale	6.45	8,970	57,856	2,959,534	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 10	Sale	6.68	36,885	246,392	2,968,504	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 09	Sale	6.59	141,664	933,566	3,005,389	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 06	Sale	6.61	25,937	171,444	3,147,053	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 05	Sale	6.29	33,267	209,249	3,172,990	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 04	Sale	6.73	23,434	157,711	3,206,257	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 03	Sale	6.66	16,440	109,490	3,299,691	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Dec 27	Sale	6.01	6,161	37,028	3,246,131	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 23	Sale	6.02	6,513	39,208	3,252,292	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 22	Sale	6.11	1,500	9,165	3,258,805	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 21	Sale	6.31	7,311	46,132	3,260,305	Dec 21 05:49 PM
CANNELL CAPITAL LLC	10% Owner	Dec 20	Sale	6.30	183,198	1,154,147	3,267,616	Dec 21 05:49 PM
CANNELL CAPITAL LLC	10% Owner	Dec 19	Sale	6.35	13,032	82,753	3,450,814	Dec 21 05:49 PM
Sullivan Keith J	President and CEO	Oct 20	Option Exercise	1.98	100,000	198,000	950,999	Oct 24 04:06 PM
Furlong Stephen	CFO	Oct 11	Sale	2.97	1,630	4,841	389,319	Oct 12 04:25 PM
MACAN WILLIAM ANDREW	Sr. VP, GC, CCO and Secretary	Oct 10	Sale	2.82	76	214	354,765	Oct 11 05:33 PM
MACAN WILLIAM ANDREW	Sr. VP, GC, CCO and Secretary	Oct 07	Sale	2.93	1,547	4,533	354,841	Oct 11 05:33 PM
Furlong Stephen	CFO	Jul 25	Sale	3.54	13,321	47,156	390,949	Jul 26 04:54 PM
Sullivan Keith J	President and CEO	Jul 18	Sale	3.72	63,466	236,094	850,999	Jul 19 04:28 PM
MACAN WILLIAM ANDREW	Sr. VP, GC, CCO and Secretary	Jul 08	Sale	3.60	2,746	9,886	356,388	Jul 11 04:11 PM
CANNELL CAPITAL LLC	10% Owner	Jun 17	Buy	3.37	1,130	3,808	3,463,846	Jun 21 04:37 PM
CANNELL CAPITAL LLC	10% Owner	Jun 16	Buy	3.09	2,576	7,960	3,462,716	Jun 21 04:37 PM
CANNELL CAPITAL LLC	10% Owner	Jun 15	Buy	3.57	1,364	4,869	3,460,140	Jun 21 04:37 PM
CANNELL CAPITAL LLC	10% Owner	Jun 14	Buy	3.57	1,347	4,809	3,458,776	Jun 14 06:00 PM
CANNELL CAPITAL LLC	10% Owner	Jun 13	Buy	3.52	1,347	4,741	3,457,429	Jun 14 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM | Neuronetics, Inc.

Upgrade your FINVIZ experience